Hepatitis E is a common infection caused by the Hepatitis E virus (HEV), a primarily enteric virus. HEV disease is mainly spread via stool contamination of water and food supplies. The virus has recently been identified as a global threat to blood safety. The seroprevalence of HEV among blood donors in Kenya remains unknown. This study was carried out as a pilot study to determine the seroprevalence of the virus among blood donors at Nairobi Blood Transfusion Center during the period from September 2018 to January 2019. A total of three hundred and fifty eight (n = 358) plasma samples were used in this study. The plasma was tested for HEV IgM and IgG antibody using a qualitative membrane-based immunoassay (Biopanda reagents Belfast UK). Demographic characteristics of the blood donors were also collected. The age of the blood donors ranged from 16 to 61 years with a mean age of 29 years (±14). Of the study subjects, 36% (n = 130) were females while 64% (n = 228) were males. Overall, 10.6% (38) and 7.8% (28) of the samples were HEV IgG and IgM seropositive respectively. Anti-HEV was distributed among all age groups; however donors aged 20 - 40 years had the highest prevalence. This study shows a relatively high prevalence of anti-HEV among healthy blood donors in Nairobi, Kenya. Further studies would be needed in other population groups to assess the potential benefit of incorporating HEV screening of blood products to the current blood donor selection criteria. Moreover, further studies to determine the circulating genotypes of HEV among this group are required for epidemiological reasons.
References
[1]
Zhang, X., Bilic, I., Troxler, S. and Hess, M. (2017) Evidence of Genotypes 1 and 3 of Avian Hepatitis E Virus in Wild Birds. Virus Research, 228, 75-78. https://doi.org/10.1016/j.virusres.2016.11.028
[2]
Woo, P.C., Lau, S.K., Teng, J.L., Cao, K.Y., Wernery, U., Schountz, T. and Yuen, K.Y. (2016) New Hepatitis E Virus Genotype in Bactrian Camels, Xinjiang, China, 2013. Emerging Infectious Diseases, 22, 2219-2221. https://doi.org/10.3201/eid2212.160979
[3]
Furukawa, N.W., Teshale, E.H., Cosmas, L., Ochieng, M., Gikunju, S., Fields, B.S. and Montgomery, J.M. (2016) Serologic Evidence for Hepatitis E Virus Infection among Patients with Undifferentiated Acute Febrile Illness in Kibera, Kenya. Journal of Clinical Virology, 77, 106-108. https://doi.org/10.1016/j.jcv.2016.02.021
[4]
Kim, J.-H., Nelson, K.E., Panzner, U., Kasture, Y., Labrique, A.B. and Wierzba, T.F. (2014) A Systematic Review of the Epidemiology of Hepatitis E Virus in Africa. BMC Infectious Diseases, 14, 308. https://doi.org/10.1186/1471-2334-14-308
[5]
Kmush, B.L., Labrique, A.B., Dalton, H.R., Ahmed, Z.B., Ticehurst, J.R., Heaney, C.D. and Zaman, K. (2015) Two Generations of “Gold Standards”: The Impact of a Decade in Hepatitis E Virus Testing Innovation on Population Seroprevalence. The American Journal of Tropical Medicine And Hygiene, 93, 714-717. https://doi.org/10.4269/ajtmh.15-0159
[6]
Guo, Y., Feng, Y., Qu, F., Zhang, L., Yan, B. and Lv, J. (2020) Prediction of Hepatitis E Using Machine Learning Models. PLoS ONE, 15, e0237750. https://doi.org/10.1371/journal.pone.0237750
[7]
Jacobs, C., Chiluba, C., Phiri, C., Lisulo, M.M., Chomba, M., Hill, P.C. and Kelly, P. (2014) Seroepidemiology of Hepatitis E Virus Infection in an Urban Population in Zambia: Strong Association with HIV and Environmental Enteropathy. Journal of Infectious Diseases, 209, 652-657. https://doi.org/10.1093/infdis/jit409
[8]
Abebe, M., Ali, I., Ayele, S., Overbo, J., Aseffa, A. and Mihret, A. (2017) Seroprevalence and Risk Factors of Hepatitis E Virus Infection among Pregnant Women in Addis Ababa, Ethiopia. PLoS ONE, 12, e0180078. https://doi.org/10.1371/journal.pone.0180078
[9]
Boon, D., Redd, A.D., Laeyendecker, O., Engle, R.E., Nguyen, H., Ocama, P. and Gray, R.H. (2018) Hepatitis E Virus Seroprevalence and Correlates of Anti-HEV IgG Antibodies in the Rakai District, Uganda. The Journal of Infectious Diseases, 217, 785-789. https://doi.org/10.1093/infdis/jix610
[10]
Ahmed, J.A., Moturi, E., Spiegel, P., Schilperoord, M., Burton, W., Kassim, N.H. and Burke, H. (2013) Hepatitis E Outbreak, Dadaab Refugee Camp, Kenya, 2012. Emerging Infectious Diseases, 19, 1010-1011. https://doi.org/10.3201/eid1906.130275
[11]
Lhomme, S., Abravanel, F., Dubois, M., Sandres-Saune, K., Rostaing, L., Kamar, N. and Izopet, J. (2012) Hepatitis E Virus Quasispecies and the Outcome of Acute Hepatitis E in Solid-Organ Transplant Patients. Journal of Virology, 86, 10006-10014. https://doi.org/10.1128/JVI.01003-12
[12]
Maponga, T.G., Lopes, T., Cable, R., Pistorius, C., Preiser, W. and Andersson, M.I. (2020) Prevalence and Risks of Hepatitis E Virus Infection in Blood Donors from the Western Cape, South Africa. VoxSanguinis. https://doi.org/10.1111/vox.12966
[13]
Stramer, S.L., Moritz, E.D., Foster, G.A., Ong, E., Linnen, J.M., Hogema, B.M. and Dodd, R.Y. (2016) Hepatitis E Virus: Seroprevalence and Frequency of Viral RNA Detection among US Blood Donors. Transfusion, 56, 481-488. https://doi.org/10.1111/trf.13355
[14]
Traore, K.A., Ouoba, J.B., Rouamba, H., Nebie, Y.K., Dahourou, H., Rossetto, F. and Roques, P. (2016) Hepatitis E Virus Prevalence among Blood Donors, Ouagadougou, Burkina Faso. Emerging Infectious Diseases, 22, 755-757. https://doi.org/10.3201/eid2204.151728
[15]
Al-Sadeq, D.W., Majdalawieh, A.F. and Nasrallah, G.K. (2017) Seroprevalence and Incidence of Hepatitis E Virus among Blood Donors: A Review. Reviews in Medical Virology, 27, e1937. https://doi.org/10.1002/rmv.1937
